Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Background: It is unclear whether antidepressants can prevent suicides or suicide attempts, particularly during long-term use. Methods: We carried out a comprehensive review of long-term studies of antidepressants (relapse prevention). Sources were obtained from 5 review articles and by searches of MEDLINE, PubMed Central and a hand search of bibliographies. We meta-analyzed placebo-controlled antidepressant RCTs of at least 3 months' duration and calculated suicide and suicide attempt incidence rates, incidence rate ratios and Peto odds ratios (ORs). Results: Out of 807 studies screened 29 were included, covering 6,934 patients (5,529 patient-years). In total, 1.45 suicides and 2.76 suicide attempts per 1,000 patient-years were reported. Seven out of 8 suicides and 13 out of 14 suicide attempts occurred in antidepressant arms, resulting in incidence rate ratios of 5.03 (0.78-114.1; p = 0.102) for suicides and of 9.02 (1.58-193.6; p = 0.007) for suicide attempts. Peto ORs were 2.6 (0.6-11.2; nonsignificant) and 3.4 (1.1-11.0; p = 0.04), respectively. Dropouts due to unknown reasons were similar in the antidepressant and placebo arms (9.6 vs. 9.9%). The majority of suicides and suicide attempts originated from 1 study, accounting for a fifth of all patient-years in this meta-analysis. Leaving out this study resulted in a nonsignificant incidence rate ratio for suicide attempts of 3.83 (0.53-91.01). Conclusions: Therapists should be aware of the lack of proof from RCTs that antidepressants prevent suicides and suicide attempts. We cannot conclude with certainty whether antidepressants increase the risk for suicide or suicide attempts. Researchers must report all suicides and suicide attempts in RCTs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large survey conducted in the United States, MDD was associated with 27.2 workdays lost per affected worker per year 204 .”
From Major depressive disorder (2016) · cites this paper as [204]
Citations
Cites
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Blumenthal, J. A., Babyak, M. A., Doraiswamy, P. M., Watkins, L., Hoffman, B. M., Barbour, K. A., Herman, S., Craighead, W. E., Brosse, A. L., Waugh, R., et al. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318148c19a · Cited by 1,019
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Reynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Stone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia
Inskip, H., Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.35 · Cited by 579
Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., & Hutton, B. (2005) · BMJ · doi:10.1136/bmj.330.7488.396 · Cited by 510
Khan, A., Warner, H. A., & Brown, W. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.4.311 · Cited by 477
Khan, A., Khan, S., Kolts, R., & Brown, W. A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.790 · Cited by 394
The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
Wasserman, D., Rihmer, Z., Rujescu, D., Sarchiapone, M., Sokolowski, M., Titelman, D., Zalsman, G., Zemishlany, Z., & Carli, V. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.06.003 · Cited by 390
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Treatment-resistant depression and suicidality
Bergfeld, I. O., Mantione, M., Figee, M., Schuurman, P. R., Lok, A., & Denys, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.016 · Cited by 256
Bipolar depression: a major unsolved challenge
Baldessarini, R. J., Vázquez, G. H., & Tondo, L. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0160-1 · Cited by 235
Placebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
The Recent Rise of Suicide Mortality in the United States
Martínez-Alés, G., Jiang, T., Keyes, K. M., & Gradus, J. L. (2022) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-051920-123206 · Cited by 146
“Knowledge of who has a high suicide risk can inform strategies for targeting evidence-based preventive interventions such as limiting access to lethal means or psychosocial interventions (17, 20, 70).”
BackgroundRoss, E. L., Zivin, K., & Maixner, D. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0768 · Cited by 150
Osler, M., Wium‐Andersen, M. K., Wium‐Andersen, I. K., Gronemann, F. H., Jørgensen, M. B., & Rozing, M. P. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13097 · Cited by 149
Li, X., Mu, F., Liu, D., Zhu, J. L., Yue, S., Liu, M., Liu, Y., & Wang, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.01.103 · Cited by 126
O’Connor, E., Perdue, L. A., Coppola, E. L., Henninger, M. L., Thomas, R. G., & Gaynes, B. N. (2023) · JAMA · doi:10.1001/jama.2023.7787 · Cited by 126
The role of prediction in suicide prevention
Large, M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/mlarge · Cited by 99
Predictors of re-attempt in a cohort of suicide attempters: A survival analysis
Irigoyen, M., Porras-Segovia, A., Galván, L., Puigdevall, M., Giner, L., De Leon, S., & Baca-García, E. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.050 · Cited by 96
Hengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 93
Moraros, J., Nwankwo, C., Patten, S. B., & Mousseau, D. D. (2017) · Depression and Anxiety · doi:10.1002/da.22584 · Cited by 105
Prevention of suicidal behavior in bipolar disorder
Tondo, L., Vázquez, G. H., & Baldessarini, R. J. (2020) · Bipolar Disorders · doi:10.1111/bdi.13017 · Cited by 104
Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?
Tondo, L., & Baldessarini, R. (2018) · Pharmacopsychiatry · doi:10.1055/a-0596-7853 · Cited by 69
“Additional studies involving mainly retrospective observations of large cohorts of depressed patients and case-control comparisons have yielded inconsistent and inconclusive findings [19, 100, 102].”
ResultAbou-Saleh, M. T., Müller-Oerlinghausen, B., & Coppen, A. J. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0080-x · Cited by 74
“Moreover, it has been shown in controlled studies that antidepressants do not reduce the suicide risk in patients with mood disorders and that in some instances particularly the SSRIs can trigger de novo suicidal ideas and behaviour even in patients who never before experienced suicidal ideas (Fergusson et al. 2005; B…”
BackgroundSuicidal Behavior in Mood Disorders: Response to Pharmacological Treatment
Tondo, L., & Baldessarini, R. J. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0715-0 · Cited by 71
Hengartner, M. P., Amendola, S., Kaminski, J. A., Kindler, S., Bschor, T., & Plöderl, M. (2021) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2020-214611 · Cited by 71
Self-citationStübner, S., Grohmann, R., Greil, W., Zhang, X., Müller-Oerlinghausen, B., Bleich, S., Rüther, E., Möller, H., Engel, R. R., Falkai, P., et al. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy048 · Cited by 70
“Nevertheless, the authors concluded that it is still unclear whether ADs increase the risk of suicide attempts (Braun et al., 2016).”
BackgroundLi, Q., Takeuchi, Y., Wang, J., Gellért, L., Barcsai, L., Pedraza, L. K., Nagy, A. J., Kozák, G., Nakai, S., Kato, S., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.013 · Cited by 68
Hong, H., Xu, L., Lu, Q., Huang, C., & Cui, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015035 · Cited by 66
Lim, K. X., Rijsdijk, F. V., Hagenaars, S. P., Socrates, A., Choi, S. W., Coleman, J. R. I., Glanville, K. P., Lewis, C. M., & Pingault, J. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003137 · Cited by 63
“This could be due to medicated patients having more severe symptoms than non-medicated patients, or to adverse effects of medication, particularly for MDD, where suicidality might be an adverse effect of antidepressant treatment [73].”
BackgroundRoss, E. L., Vijan, S., Miller, E. M., Valenstein, M., & Zivin, K. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1480 · Cited by 50
“On the basis of meta-analyses showing no significant change in suicide risk with antidepressants (50) or psychotherapy (51), we did not model an effect of depression treatment on suicide mortality.”
Barroilhet, S. A., & Ghaemi, S. N. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13202 · Cited by 56
“Consequently, for suicide prevention, these randomized studies of lithium and of antidepressants demonstrate that using lithium more widely and using antidepressants less would be more consistent with our best scientific evidence (31,32).”
BackgroundA meta-analysis of the effects of ketamine on suicidal ideation in depression patients
Shen, Z., Gao, D., Lv, X., Wang, H., & Yue, W. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02973-1 · Cited by 55
Jobes, D. A., & Chalker, S. A. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193606 · Cited by 52
“Data on the effectiveness of anti-depressants with suicidal risk are quite mixed [10].”
BackgroundZhang, R., Wei, S., Chang, M., Jiang, X., Tang, Y., & Wang, F. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.45 · Cited by 51
“Although medications did not differ significantly with respect to the groups with MDD with and without suicidal ideation, it is unclear how antidepressants affect the risk of suicide (Braun et al., 2016).”
BackgroundPrevention of suicidal behavior with lithium treatment in patients with recurrent mood disorders
Tondo, L., & Baldessarini, R. J. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00326-x · Cited by 50
Huang, X., Harris, L. M., Funsch, K. M., Fox, K. R., & Ribeiro, J. D. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02173-9 · Cited by 49
Scotton, E., Antqueviezc, B., Vasconcelos, M., Dalpiaz, G., Géa, L. P., Goularte, J. F., Colombo, R., & Rosa, A. R. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114963 · Cited by 40
Effects of somatic treatments on suicidal ideation and completed suicides
Hawkins, E. M., Coryell, W. H., Leung, S., Parikh, S. V., Weston, C. L., Nestadt, P. S., Nürnberger, J. I., Kaplin, A. I., Kumar, A., Farooqui, A. A., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2381 · Cited by 31
Cohen, I. V., Makunts, T., Atayee, R. S., & Abagyan, R. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01590-x · Cited by 29
Antidepressants and suicidality: A re-analysis of the re-analysis
Kaminski, J. A., & Bschor, T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.107 · Cited by 28
Self-citationSuicidality in Fibromyalgia: A Systematic Review of the Literature
Levine, D. S., & Horesh, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.535368 · Cited by 25
“However, research is inconclusive regarding whether or not psychopharmacological medications can actually prevent suicide (58, 59).”
BackgroundTargeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression
Zhou, X., Bao, W.-D., Liu, D., & Zhu, L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191101124017 · Cited by 24
Michel, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105301 · Cited by 26
Zeng, Y., Li, W., Chen, X., You, Z., Mai, S., Lan, X., Ning, Y., & Zhou, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.078 · Cited by 22
Odermatt, J., Sarlon, J., Schaefer, N., Ulrich, S., Ridder, M., Schneider, E., Lang, U. E., Liwinski, T., & Brühl, A. B. (2025) · Neuroscience Applied · doi:10.1016/j.nsa.2025.105520 · Cited by 19
“Importantly, there remains a lack of evidence from randomized controlled trials (RCTs) supporting the efficacy of antidepressants in preventing suicides and suicide attempts (Braun et al., 2016).”
Lengvenytė, A., Giner, L., Jardon, V., Olié, É., Pérez, V., Sáiz, P. A., González-Pinto, A. M., & Courtet, P. (2023) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2023.12.001 · Cited by 19
Göhler, A. C., Haas, J. W., Sperl, M. F. J., Hermann, C., & Winkler, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.037 · Cited by 19
On the Randomness of Suicide: An Evolutionary, Clinical Call to Transcend Suicide Risk Assessment
Soper, C. A., Ocejo, P. M., & Large, M. M. (2022) · Evolutionary Psychiatry · doi:10.1017/9781009030564.011 · Cited by 16
Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis
Zhang, L., Sander, J. W. A. S., Zhang, L., Jiang, X., Wang, W., Shuang, K., Abdulaziz, A. T. A., Wu, M., Chi, X., Li, J., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8626-5 · Cited by 15
“As for treatment, apart from first-line immunotherapies [intravenous immunoglobulin (IVIG) and methylprednisolone (MTP)], some also received drugs which have been related to possible suicidality, including levetiracetam (LEV) [21, 22] and antidepressants [23, 24].”
BackgroundWang, H., Lyu, N., Huang, J., Fu, B., Shang, L., Yang, F., Zhao, Q., & Wang, G. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05726-y · Cited by 15
Meta-analysis of sleep deprivation effects on depression in rodents
Hu, B., Liu, C., Lv, T., Luo, F., Qian, C., Zhang, J., Ye, M., & Liu, Z. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147841 · Cited by 12
What psychologists need to know about psychotropic medications
Tomba, E., Guidi, J., & Fava, G. A. (2018) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2154 · Cited by 11
Lohse, M. J., Seifert, J., & Bleich, S. (2021) · Springer eBooks · doi:10.1007/978-3-662-63825-5_39 · Cited by 11
Nguyen, T. M. L., Jollant, F., Tritschler, L., Colle, R., Corruble, E., & Gardier, A. M. (2023) · Pharmaceuticals · doi:10.3390/ph16040634 · Cited by 11
“47 per 100 patients per year, respectively, which are twice and ten times higher than in people suffering from non-resistant depression [10].”
Zainal, N. H. (2023) · Psychological Medicine · doi:10.1017/s0033291723003306 · Cited by 10
Civardi, S. C., Besana, F., Miacca, G. C., Mazzoni, F., Arienti, V., Politi, P., Brondino, N., & Olivola, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1371139 · Cited by 10
“These are respectively twice and ten times greater than those found in non-resistant patients: 0.22 completed and 0.43 attempted suicides per 100 patients/year (12).”
InfluentialMichel, K., Gysin-Maillart, A., Breit, S., Walther, S., & Pavlidou, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.068 · Cited by 10
Lohse, M. J., & Müller-Oerlinghausen, B. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_41 · Cited by 10
Teismann, T., Düwel, H., Eidt, L., Brailovskaia, J., & Cwik, J. C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.873127 · Cited by 8
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 8
Circadian Pattern of Deaths Due to Suicide in Intoxicated Alcohol-Dependent Individuals
Chakravorty, S., Vickers‐Smith, R., Perlis, M. L., Grandner, M. A., & Kranzler, H. R. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11800 · Cited by 8
Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X
Chart‐Pascual, J. P., Goena, J., Lara-Abelenda, F. J., Torres, M., Napal, J. M., Muñoz, R., Montero, C. G., Fraile‐Μartinez, O., Ortega, M. A., de Pablo, G. S., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10 · Cited by 7
Prevention of Suicidal Behavior in Bipolar Disorder
Tondo, L., Vázquez, G. H., & Baldessarini, R. J. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021025 · Cited by 7
Lohse, M. J., & Müller-Oerlinghausen, B. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_41 · Cited by 7
Varki, A. P. (2019) · Evolutionary psychology · doi:10.1007/978-3-030-25466-7_6 · Cited by 6
Chen, Q., Li, Y., Hu, Y., Liang, W., & Zhang, B. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054479 · Cited by 6
Li, J., Ma, L., Sun, H., Li, M., Cao, Y., Peng, Y., & Xu, J. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01920-x · Cited by 5
“Although tradi - tional antidepressants have some anti-suicidal effects, their slow onset of action increases the risk of suicide at the early stages of treatment [ 51, 52 ].”
Xin, Q., Paudel, D., Li, L., Zhang, B., & Yin, H. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2760 · Cited by 5
Lohse, M. J. (2020) · Springer eBooks · doi:10.1007/978-3-662-62168-4_38 · Cited by 5
A Critique on Psychiatric Inpatient Admissions for Suicidality in Youth
Safer, D. J. (2021) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001335 · Cited by 5
Amendola, S., Plöderl, M., & Hengartner, M. P. (2024) · Crisis · doi:10.1027/0227-5910/a000941 · Cited by 4
Affektive Störungen am Beispiel der unipolaren Depression
Köhler, S., & Walter, H. (2020) · Springer eBooks · doi:10.1007/978-3-662-59038-6_12 · Cited by 4
Lohse, M. J., & Müller-Oerlinghausen, B. (2019) · Springer eBooks · doi:10.1007/978-3-662-59046-1_41 · Cited by 4
Binder, M. R. (2023) · International Journal of Psychiatry Research · doi:10.33425/2641-4317.1167 · Cited by 4
“By comparison, treatment with antidepressant drugs has been found to increase the risk of suicidality between 2 [81] and 10-fold [82-84].”
Meta-analysis of the effects of sleep deprivation on depression in patients and animalsPreprint
Hu, B., Ye, M., Feng, D., Ying, J., Mou, T., Luo, F., Lv, T., Jiang, L., Qian, C., Ding, Z., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.971689 · Cited by 4
“antidepressants [5, 6].”
Eggart, M., Valdés‐Stauber, J., & Müller-Oerlinghausen, B. (2025) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.70041 · Cited by 3
Hasler, F. (2023) · transcript Verlag eBooks · doi:10.14361/9783839445716 · Cited by 3
Wandel von Nutzen und Risiko antidepressiver Pharmakotherapie
Baethge, C. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01672-y · Cited by 3
Self-citationLithium heute — ein Update seiner Wirksamkeit und Risiken
Müller-Oerlinghausen, B. (2019) · NeuroTransmitter · doi:10.1007/s15016-019-6601-3 · Cited by 3
Generalization and enhancement of the effects of an active placebo nasal spray on sadness
Wilhelm, M., Fischer, S. M., Rief, W., Fiorio, M., & Barbiani, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.045 · Cited by 3
Bronisch, T. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6214-2 · Cited by 3
Suicidal behavior and substance dependence
Schneider, B., Meiländer, L., & Wetterling, T. (2025) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/207291 · Cited by 2
Geng, L., Zhang, S., Yan, J., & Wang, R. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s519787 · Cited by 2
“21 Specifically, the inability to identify subgroups at high risk of SB that are resistant to conventional interventions highlights the need to develop refined predictive models that integrate biomarkers.”
Men and suicide: Primary care prevention in the era of COVID-19 and beyond
Adler, R. H. (2021) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000614 · Cited by 2
“A problem is that there is little evidence that antidepressants are effective in preventing suicide (Braun et al., 2016).”
BackgroundThe problem of suicide in depression in the modern world
Петрова, Н. Н. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212206243 · Cited by 2
Pengaruh Pemberian Obat Antidepresan terhadap Risiko Bunuh Diri: Literatur Review
Hasanah, F. F., Hilmi, I. L., & Salman, S. (2023) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v6i2.37 · Cited by 2
“…(2002-2013) 174,2 (95% CI; 4,4 - 970,5) Pemberian obat antidepresan menunjukkan adanya penurunan angka kasus bunuh diri dan percobaan bunuh diri dibandingkan dengan pemberian plasebo Braun et al., 2016 Uji coba Randomized Comparing Trials (RCTs) pemberian antidepresan dan plasebo jangka panjang.”
BackgroundInfluentialFlink, N. (2019) · UEF eRepo (University of Eastern Finland) · Cited by 2
Suicide: An Immunological Disorder?Preprint
O'Connor, K. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3783063 · Cited by 1
Yang, K.-Y., Yoo, G., Kim, C. H., Lim, S., & Jeon, J. (2024) · The Korean Journal of Community Living Science · doi:10.7856/kjcls.2024.35.3.497 · Cited by 1
Hao, X., Wang, L., Dou, L., Huang, Y., Chen, J., & Sun, P. (2025) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2025.2510244 · Cited by 1
“…has been debate (Berwian et al., 2017). some studies have confirmed that receiving antidepressants may lead to more suicide attempts by patients (Braun et al., 2016). however, other studies have shown that antidepressant medications reduce the incidence of suicide attempts (Kupfer et al.,…”
Keine hochwertige Evidenz für Verhinderung von Suiziden durch Antidepressiva und Clozapin
Baethge, C. (2016) · Der Nervenarzt · doi:10.1007/s00115-016-0209-7 · Cited by 1
Self-citationSuicide in psychiatric disorders: rates, risk factors, and therapeutics
Tondo, L., & Baldessarini, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821033-8.00004-6 · Cited by 1
Lohse, M. J., & Müller-Oerlinghausen, B. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_41 · Cited by 1
Suicides in Poland in the context of depression pharmacotherapy
Pawlak, J., & Dmitrzak‐Węglarz, M. (2021) · Pharmacotherapy in Psychiatry and Neurology · doi:10.5114/fpn.2021.115647 · Cited by 1
“The authors of a 2016 meta-analysis came to the opposite conclusion (Braun et al., 2016).”
BackgroundPharmacological Treatment of Suicidality in Affective and Psychotic Disorders
Bronisch, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-42003-1_69 · Cited by 1
Assessment and Management of Suicidal Risk
Melvin, G. A., Oquendo, M. A., Stanley, B., & Posner, K. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_67-1 · Cited by 1
Suizidrisiko und Suizidprävention
Lewitzka, U., & Felber, W. (2022) · Springer eBooks · doi:10.1007/978-3-662-65734-8_29 · Cited by 1
Wasserman, D. (2022) · Oxford University Press eBooks · doi:10.1093/acrefore/9780190632366.013.302 · Cited by 1
Klöppel, S., Brieger, P., & Assion, H. (2017) · Elsevier eBooks · doi:10.1016/b978-3-437-21155-3.00021-6
Scotton, E. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Re: More evidences are needed in reducing the suicide risk in head and neck cancer patients
Twigg, J., Anderson, J. M., Humphris, G. M., Nixon, I. J., Rogers, S. N., & Kanatas, A. N. (2021) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2020.09.042
Gefängnissuizid in Deutschland
Opitz‐Welke, A. (2021) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-30412
Pharmacological Treatment of Suicidality in Affective and Psychotic Disorders
Bronisch, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-41319-4_69-1
Lewitzka, U., & Knappe, S. (2021) · PSYCH up2date · doi:10.1055/a-1211-7017
“[38] Braun C, Bschor T, Franklin J et al.”
Affective Disorders Using the Example of Unipolar Depression
Köhler, S., & Walter, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-65774-4_12
Metadata
- Authors
- Braun, C., Bschor, T., Franklin, J., & Baethge, C.
- Affiliations
- University of Cologne (DE)
- Schlosspark-Klinik (DE)
- University Hospital Cologne (DE)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 3
- Pages
- 171-179
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2314831905
- Cited by
- 103
- References
- 71
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 12 · 2019: 9 · 2018: 10 · 2017: 5 · 2016: 6
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressants, suicide, suicide attempts, major depressive disorder, long-term treatment, relapse prevention, incidence rate ratio, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Long-Term Care, Risk Factors, Suicide, Attempted, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.